Webinar: ctDNA in Field of Liquid Biopsy | Thermo Fisher Scientific

This workshop, sponsored by Thermo Fisher Scientific, is part of the Association of Molecular Pathology's AMP 2020 virtual conference held November 16-20, 2020.

Speaker: Kelli S. Bramlett, Director, R&D Life Sciences Solution Group, Thermo Fisher Scientific
Duration: 39 minutes

Overview:
Liquid Biopsy is a non-invasive method for identifying biomarkers present in circulating tumor DNA (ctDNA). Recent ctDNA detectiontechnologies could potentially revolutionize early cancer detection. As liquid biopsy technologies become more sensitive, screening for early cancer detection using a blood test could become routine clinical practice. However, with the advent of new technologies comes an equally important need for novel reference materials and quality assessment schemes to ensure quality test implementation.

Complete the form below to access the webinar recording.

CE credit not available for this webinar.

Critical Role of ctDNA Reference Materials in the Field of Liquid Biopsy

*Required field

Email Address

First Name

Last Name

Job Title

Institution

City

Zip or Postal Code

Learn more and stay informed.

I would like to learn more about Quality Controls. Please have a Thermo Fisher Scientific representative contact me.

To ensure that we are complying with your preferences, we need to confirm permission to send you communications by email.

I would like to receive emails about relevant Thermo Fisher Scientific™ information and promotions. By selecting this option, you are acknowledging that you have read and understand our Privacy Policy.

Webinar: Critical Role of Circulating Tumor DNA Reference Materials in the Field of Liquid Biopsy

Learn more and stay informed.